Correction to GPR103 Antagonists Demonstrating Anorexigenic

Correction to GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2 ... Publication Date (Web): April 15...
0 downloads 0 Views 114KB Size
Addition/Correction pubs.acs.org/jmc

Correction to GPR103 Antagonists Demonstrating Anorexigenic Activity in Vivo: Design and Development of Pyrrolo[2,3‑c]pyridines That Mimic the C‑Terminal Arg-Phe Motif of QRFP26 Jennie Georgsson, Fredrik Bergström, Anneli Nordqvist,* Martin J. Watson, Charles D. Blundell, Magnus J. Johansson, Annika U. Petersson, Zhong-Qing Yuan, Yiqun Zhou, Lisbeth Kristensson, Dorota Kakol-Palm, Christian Tyrchan, Eric Wellner, Udo Bauer, Peter Brodin, and Anette Svensson Henriksson Journal of Medicinal Chemistry 2014, 57, 5935−5948. DOI: 10.1021/jm401951t Page 5938. For Table 1, some entries should be the following: Compound 25a column 3 should be 4-CH3 instead of 3CH3. Compound 25c column 3 should be 3-CH3 instead of 4CH3. Compound 25e column 3 should be (+)-4-CH3 instead of (+)-7-CH3. Compound 25f column 3 should be (−)-4-CH3 instead of (−)-7-CH3.

Published: April 15, 2015 © 2015 American Chemical Society

4086

DOI: 10.1021/acs.jmedchem.5b00479 J. Med. Chem. 2015, 58, 4086−4086